XML 213 R51.htm IDEA: XBRL DOCUMENT v3.22.0.1

Share-based Payment Expense (Tables)

12 Months Ended

Dec. 31, 2021

Statement [line items]

Summary of Share-based Payment Expense

		2021 $m				2020 $m				2019 $m
Performance Share Plans and Restricted Share Plan expense			108				93				79
Share option expense			2				3				4
Total share-based payment expense (i)			110				96				83

(i) The total share-based payment expense in 2019, including discontinued operations, amounted to $86 million.

Summary of Movement and Options Outstanding Under Share Option Schemes

Details of movement and options outstanding under Share Option Schemes (excluding Savings-related Share Option Schemes)

		Weighted average exercise price				Number of options 2021								Weighted average exercise price				Number of options 2020								Weighted average exercise price				Number of options 2019
Outstanding at beginning of year											€16.19												197,253																€16.19				278,349								€16.48				800,770
Exercised (i)			€16.19				(51,522)								€16.19				(77,748)								€16.65				(520,115)
Lapsed			-				-								€16.19				(3,348)								€16.19				(2,306)
Outstanding at end of year (ii)			€16.19				145,731								€16.19				197,253								€16.19				278,349
Exercisable at end of year			€16.19				145,731								€16.19				197,253								€16.19				278,349

(i) The weighted average share price at the date of exercise of these options was €42.10 (2020: €31.70; 2019: €29.10).

(ii) All options granted have a life of ten years. All outstanding options are denominated in euro and have an exercise price of €16.19 (2020: €16.19; 2019: €16.19).

Summary of Weighted Average Remaining Contractual Life for Share Options Outstanding

				2021				2020				2019
Weighted average remaining contractual life for the share options outstanding at 31 December (years)					1.30				2.30				3.30

Summary of Weighted Fair Values Assigned to Options Issued Under the Savings-Related Share Option Schemes

The weighted fair values assigned to options issued under the Savings-related Share Option Schemes, which were computed in accordance with the trinomial valuation methodology, were as follows:

		3-year				5-year
Granted in 2021 (October)			€6.78			€	7.05
Granted in 2019 (April)			€7.55			€	7.98
Granted in 2019 (May)			€6.67			€	7.19

Summary of Assumptions of Fair Value Options

Details of awards granted under the 2014 Performance Share Plan

										Number of shares
		Share price at date of award				Period to earliest release date				Initial award (i)				Net outstanding at 31 December 2021
Granted in 2021			€39.79				3 years				3,261,885				3,154,225
Granted in 2020			€31.50				3 years				3,428,021				3,232,561
Granted in 2019			€29.44				3 years				3,688,027				3,352,346

(i) Numbers represent the initial awards including those granted to employees of Europe Distribution in 2019. The Remuneration Committee has determined that dividend equivalents will accrue on awards under the 2014 Performance Share Plan. Subject to satisfaction of the applicable performance criteria, such dividend equivalents will be released to participants in the form of additional shares on vesting.

25% of each award made is subject to TSR performance measured against a tailored peer group; 25% is subject to a RONA metric; with the remaining 50% subject to a cumulative cashflow

metric. Performance for the awards will be assessed over a three-year period.

The fair values assigned to the portion of awards which are subject to TSR performance against

peers was €22.23 (2020: €18.52; 2019: €18.59). The fair value of these awards was calculated using a TSR pricing model taking account of peer group TSR, volatilities and correlations together with the following assumptions:

2014 Performance Share Plan [member]

Statement [line items]

Summary of Assumptions of Fair Value Options

The fair value of these awards was calculated using a TSR pricing model taking account of peer group TSR, volatilities and correlations together with the following assumptions:

		2021				2020				2019
Risk-free interest rate (%)			(0.56)				(0.61)				(0.37)
Expected volatility (%)			35.1				22.1				23.2

2010 Savings Related Share Option Schemes [member]

Statement [line items]

Summary of Movement and Options Outstanding Under Share Option Schemes

Details of options granted under the Savings-related Share Option Schemes

Weighted average exercise price

Number of options 2021

Weighted average exercise price

Number of options 2020

Weighted average exercise price

Number of options 2019

Outstanding at beginning of year

€23.83/Stg£19.69

1,173,507

€23.67/Stg£20.17

1,508,862

€22.15/Stg£18.74

1,686,176

Exercised (i)

€22.77/Stg£18.69

(470,001)

€23.21/Stg£22.37

(178,773)

€19.09/Stg£16.20

(627,034)

Lapsed

€24.75/Stg£21.49

(73,411)

€23.25/Stg£21.54

(156,582)

€23.49/Stg£20.85

(207,070)

Granted (ii)

Stg£31.04

455,068

-

-

€24.24/Stg£20.11

656,790

Outstanding at end of year

€24.28/Stg£25.42

1,085,163

€23.83/Stg£19.69

1,173,507

€23.67/Stg£20.17

1,508,862

Exercisable at end of year

€23.27/Stg£20.56

14,197

€24.66/Stg£24.51

16,528

€18.88/Stg£15.89

13,065

(i) The weighted average share price at the date of exercise of these options was €42.53 (2020: €31.70; 2019: €28.52).

(ii) Pursuant to the 2010 and 2021 Savings-related Share Option Schemes operated by the Group, employees were granted options over 455,068 of CRH plc’s Ordinary Shares in October 2021 (2020: nil; 2019: 556,493 share options in April 2019 and 100,297 share options in May 2019). This figure comprises options over 346,237 (2020: nil; 2019: 518,944) shares and 108,831 (2020: nil; 2019: 137,846) shares which are normally exercisable within a period of six months after the third or the fifth anniversary of the contract, whichever is applicable. The exercise price at which the options are granted under the scheme represents a discount of 15% to the market price on the date of invitation of each savings contract. 

Summary of Weighted Average Remaining Contractual Life for Share Options Outstanding

		2021				2020				2019
Weighted average remaining contractual life for the share options outstanding at 31 December (years)			1.81				1.14				1.87
euro-denominated options outstanding at end of year (number)			132,769				214,826				290,627
Range of exercise prices (€)			20.83-27.86				20.83-27.86				17.67-27.86
Pound Sterling-denominated options outstanding at end of year (number)			952,394				958,681				1,218,235
Range of exercise prices (Stg£)			16.16-31.04				16.16-24.51				14.94-24.51

Summary of Assumptions of Fair Value Options

The fair value of these options were determined using the following assumptions:

		2021												2019
		3-year				5-year								3-year								5-year
			October												April				May				April				May
Weighted average exercise price (€)			36.83				36.83								23.30				24.24				23.30				24.24
Risk free interest rate (%)			(0.61)				(0.43)								(0.56)				(0.58)				(0.40)				(0.41)
Expected dividend payments over the expected life (€)			3.25				5.65								2.34				2.34				4.06				4.06
Expected volatility (%)			23.5				21.2								19.6				20.0				21.1				21.3
Expected life in years			3				5								3				3				5				5

X

- Definition

Disclosure of detailed information about weighted fair values assigned to options issued under the savings-related share option schemes explanatory.

+ References

No definition available.

+ Details

Name:	crh_DisclosureOfDetailedInformationAboutWeightedFairValuesAssignedToOptionsIssuedUnderTheSavingsrelatedShareOptionSchemesExplanatory
Namespace Prefix:	crh_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Disclosure Of Fair Value Of Options Determined Using Assumptions [Text block]

+ References

No definition available.

+ Details

Name:	crh_DisclosureOfFairValueOfOptionsDeterminedUsingAssumptionsExplanatory
Namespace Prefix:	crh_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Disclosure Of Number And Weighted Average Remaining Contractual Life And Range Of Exercise Prices Of Outstanding Share Options [text block]

+ References

No definition available.

+ Details

Name:	crh_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeAndRangeOfExercisePricesOfOutstandingShareOptionsExplanatory
Namespace Prefix:	crh_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Disclosure of detailed information about share based compensation expense.

+ References

No definition available.

+ Details

Name:	crh_DisclosureOfShareBasedCompensationExpenseExplanatory
Namespace Prefix:	crh_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	crh_StatementLineItems
Namespace Prefix:	crh_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2021-01-01
-Paragraph 45
-Subparagraph b
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b&doctype=Standard
-URIDate 2021-03-24

+ Details

Name:	ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=crh_PerformanceSharePlansMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=crh_TwoThousandTenSavingsRelatedShareOptionSchemesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: